PD-L1 expression in tumor tissue and peripheral blood of patients with oral squamous cell carcinoma

BACKGROUND: Immune checkpoints like programmed cell death-1 (PD-1) and its ligand PD-L1 are involved in immune escape mechanisms of solid tumors including oral squamous cell carcinoma (OSCC). Inhibitors of the pathway are successfully used for treating especially advanced disease. However, the physi...

Descripción completa

Detalles Bibliográficos
Autores principales: Weber, Manuel, Wehrhan, Falk, Baran, Christoph, Agaimy, Abbas, Büttner-Herold, Maike, Preidl, Raimund, Neukam, Friedrich W., Ries, Jutta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762533/
https://www.ncbi.nlm.nih.gov/pubmed/29348848
http://dx.doi.org/10.18632/oncotarget.22576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762533/
https://www.ncbi.nlm.nih.gov/pubmed/29348848
http://dx.doi.org/10.18632/oncotarget.22576

Ejemplares similares